BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31568815)

  • 1. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of computational approaches to understand cancer biology for informed drug repurposing.
    Ahmed F; Samantasinghar A; Soomro AM; Kim S; Choi KH
    J Biomed Inform; 2023 Jun; 142():104373. PubMed ID: 37120047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based drug repositioning: Potential and limits.
    Adasme MF; Parisi D; Sveshnikova A; Schroeder M
    Semin Cancer Biol; 2021 Jan; 68():192-198. PubMed ID: 32032699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing for breast cancer therapy: Old weapon for new battle.
    Aggarwal S; Verma SS; Aggarwal S; Gupta SC
    Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
    Iwata M; Hirose L; Kohara H; Liao J; Sawada R; Akiyoshi S; Tani K; Yamanishi Y
    J Med Chem; 2018 Nov; 61(21):9583-9595. PubMed ID: 30371064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repositioning in cancer: The current situation in Japan.
    Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
    Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing for cancer therapy, easier said than done.
    Gonzalez-Fierro A; Dueñas-González A
    Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy.
    Rauf A; Joshi PB; Olatunde A; Hafeez N; Ahmad Z; Hemeg HA; Aljohani ASM; Al Abdulmonem W; Thiruvengadam M; Viswanathan D; Rajakumar G; Thiruvengadam R
    Med Oncol; 2024 Apr; 41(5):122. PubMed ID: 38652344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.
    Sohraby F; Aryapour H
    Semin Cancer Biol; 2021 Jan; 68():249-257. PubMed ID: 32360530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational drug repositioning for cancer therapeutics.
    Jiao M; Liu G; Xue Y; Ding C
    Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Drug Repositioning Approaches and Resources.
    Xue H; Li J; Xie H; Wang Y
    Int J Biol Sci; 2018; 14(10):1232-1244. PubMed ID: 30123072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Recent Developments and Progress in Computational Drug Repositioning.
    Shi W; Chen X; Deng L
    Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repositioning by merging active subnetworks validated in cancer and COVID-19.
    Lucchetta M; Pellegrini M
    Sci Rep; 2021 Oct; 11(1):19839. PubMed ID: 34615934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.